Health Bulletin 16/December/2022

Published On 2022-12-16 11:10 GMT   |   Update On 2022-12-16 11:10 GMT

Here are the top health news for the day:NMC re-invites applications for establishment of new medical colleges, intake increase of MBBS, PG medical seats, starting new PG coursesNoting that many institutes missed the opportunity to submit their requests, the National Medical Commission (NMC) has reactivated the online portal for applications by medical institutions seeking permission for...

Login or Register to read the full article

Here are the top health news for the day:

NMC re-invites applications for establishment of new medical colleges, intake increase of MBBS, PG medical seats, starting new PG courses

Noting that many institutes missed the opportunity to submit their requests, the National Medical Commission (NMC) has reactivated the online portal for applications by medical institutions seeking permission for the establishment of new medical colleges and intake increase of MBBS and PG medical seats or starting new PG courses for the academic year 2023-24. The deadline for the same is set till 23 December 2022.

For the Academic Session 2023-24, the last date for submitting applications for the MBBS course was 31st August 2022 and Post Graduate Courses was 20th, July 2022.

For more details, check out the link given below:

NMC Re-Invites Applications For Establishment Of New Medical Colleges, Intake Increase Of MBBS, PG Medical Seats, Starting New PG Courses


CDSCO opines J&J to submit details of anticancer drug Teclistamab approval in EU, US

In response to the drug major Johnson & Johnson proposal to import and market Teclistamab sterile liquid in vial 30mg/vial and 90mg/vial, the Subject Export Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has opined the firm to submit patients characteristics along with transplant history if any, treatment details and details of approval of the drug in EU and US for further deliberation.

For more details, check out the link given below:

CDSCO Opines J&J To Submit Details Of Anticancer Drug Teclistamab Approval In EU, US

Dr Sanjeev Gulati takes charge as 52nd president of Indian Society Of Nephrology

Dr Sanjeev Gulati, Executive Director, Nephrology and Kidney Transplant of Fortis Group of Hospitals, NCR has recently been elected as the President of the Indian Society of Nephrology (ISN). He was appointed as the 52nd President of ISN at its annual conference in Pune.

Congratulating the doctor over the great success, Fortis Hospital authorities stated that this evaluation of the doctor serves as a testament to his lifelong commitment towards the well-being of patients.

For more details, check out the link given below:

Dr Sanjeev Gulati Takes Charge As 52nd President Of Indian Society Of Nephrology


Madras HC raps Govt for withholding certificates of doctors, orders to ensure immediate bond service postings

Expressing concern over delayed bond service postings, the Madras High Court has recently slammed the Government for forcing super speciality and post graduate doctors to be idle by withholding their educational certificates.

The HC bench comprising Justice R. Subramanian also took note of the fact that the State Health Department of Tamil Nadu is neither offering government jobs to doctors who need to fulfill two-year bond service conditions after passing out of the government medical colleges, nor releasing their educational certificates. Therefore, these doctors are not even able to pursue higher education or get private jobs.

For more details, check out the link given below:

Madras HC raps govt for withholding certificates of doctors, orders to ensure immediate bond service postings

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Health Bulletin 04/ May/ 2024
Health Bulletin 03/ May/ 2024
Health Bulletin 02/ May/ 2024
Health Bulletin 01/April/ 2024